BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7824230)

  • 1. The role of endocervical curettage at cervical conization for high-grade dysplasia.
    Kobak WH; Roman LD; Felix JC; Muderspach LI; Schlaerth JB; Morrow CP
    Obstet Gynecol; 1995 Feb; 85(2):197-201. PubMed ID: 7824230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pre- and postoperative value of endocervical curettage in the detection of cervical intraepithelial neoplasia and invasive cervical cancer.
    Fine BA; Feinstein GI; Sabella V
    Gynecol Oncol; 1998 Oct; 71(1):46-9. PubMed ID: 9784317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors from cold knife conization for residual cervical intraepithelial neoplasia in subsequent hysterectomy.
    Moore BC; Higgins RV; Laurent SL; Marroum MC; Bellitt P
    Am J Obstet Gynecol; 1995 Aug; 173(2):361-6; discussion 366-8. PubMed ID: 7645609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of High-Grade Histopathology Diagnosed by Cervical Conization in Endocervical Curettage Cervical Intraepithelial Neoplasia 1: A Case-Control Study.
    Cong Q; Xiao J; Tao X; Sui L
    J Low Genit Tract Dis; 2020 Jul; 24(3):247-251. PubMed ID: 32324695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Abnormal Precone Endocervical Curettage Result Is an Independent Risk Factor for Positive Margins in Conization Specimens.
    An J; Lei H; Xie X; Sun P
    Oncol Res Treat; 2020; 43(10):518-525. PubMed ID: 32772026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic variables predictive of residual dysplasia after cervical conization.
    Schermerhorn TJ; Hodge J; Saltzman AK; Hackett TE; Sprance HE; Harrison TA
    J Reprod Med; 1997 Apr; 42(4):189-92. PubMed ID: 9131490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of endocervical curettage with conization in diagnosis of endocervical lesions.
    Suzuki Y; Cho T; Mogami T; Yokota NR; Matsunaga T; Asai-Sato M; Hirahara F; Nojima M; Mori M; Miyagi E
    J Obstet Gynaecol Res; 2017 Apr; 43(4):723-728. PubMed ID: 28168772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical outcome and high risk factor for residual lesion analysis of HSIL half a year after loop electrosurgical excision procedure: a clinical study of 1 502 cases].
    Liu L; Chen LM; Tao X; Dai F; Guo LP; Zhang HW; Zhou XR; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):751-756. PubMed ID: 29179270
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen.
    Roman LD; Felix JC; Muderspach LI; Agahjanian A; Qian D; Morrow CP
    Obstet Gynecol; 1997 Nov; 90(5):759-64. PubMed ID: 9351760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat surgery in patients with cervical cancer stage FIGO IA1: a series of 156 cases and a review of the literature.
    Hefler LA; Polterauer S; Schneitter A; Concin N; Hofstetter G; Bentz E; Leipold H; Tempfer C; Reinthaller A
    Anticancer Res; 2010 Feb; 30(2):565-8. PubMed ID: 20332471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-conization endocervical curettage for estimating the risk of persistent or recurrent high-grade dysplasia.
    Shaco-Levy R; Meirovitz M; Eger G; Benharroch D; Dreiher J
    Int J Gynaecol Obstet; 2013 Apr; 121(1):49-52. PubMed ID: 23332656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia.
    Barlin JN; Bristow RE; Murillo AM; Zahurak M; Veras E; Salani R
    J Reprod Med; 2010; 55(3-4):129-33. PubMed ID: 20506673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial and endocervical curettage findings at the time of cervical conization.
    Presley JJ; Hernandez E; Mudafort E; Miyazawa K
    J Reprod Med; 1987 Feb; 32(2):99-102. PubMed ID: 3560085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in HIV-positive women.
    Holcomb K; Matthews RP; Chapman JE; Abulafia O; Lee YC; Borges A; Buhl A
    Gynecol Oncol; 1999 Sep; 74(3):428-31. PubMed ID: 10479504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
    Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
    Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
    Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
    Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of positive margins in loop electrosurgical cone biopsies.
    Felix JC; Muderspach LI; Duggan BD; Roman LD
    Obstet Gynecol; 1994 Dec; 84(6):996-1000. PubMed ID: 7970484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of persistence or recurrence after conization for cervical intraepithelial neoplasia III.
    Lu CH; Liu FS; Kuo CJ; Chang CC; Ho ES
    Obstet Gynecol; 2006 Apr; 107(4):830-5. PubMed ID: 16582119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for residual disease in subsequent hysterectomy following conization for CIN III.
    Lu CH; Liu FS; Tseng JJ; Ho ES
    Gynecol Oncol; 2000 Nov; 79(2):284-8. PubMed ID: 11063658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of invasive adenocarcinoma after conization for cervical adenocarcinoma in situ.
    ElMasri WM; Walts AE; Chiang A; Walsh CS
    Gynecol Oncol; 2012 Jun; 125(3):589-93. PubMed ID: 22410327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.